Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia

Journal of the American College of Cardiology - Tập 62 - Trang 1154-1162 - 2013
Christie M. Ballantyne1,2, Michael H. Davidson3, Diane E. MacDougall4, Harold E. Bays5, Lorenzo A. DiCarlo4, Noah L. Rosenberg4, Janice Margulies4, Roger S. Newton4
1Department of Medicine, Baylor College of Medicine, Houston, Texas
2Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas
3Pritzker School of Medicine, University of Chicago, Chicago, Illinois
4Esperion Therapeutics, Inc., Plymouth, Michigan
5Louisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky

Tài liệu tham khảo